Doug Langa

Executive vice president, North America Operations
 

Doug Langa, Executive vice president, North America Operations

Novo Nordisk

Mr Langa joined Novo Nordisk in 2011 as senior director of Managed Markets. In 2015 Mr Langa was promoted to corporate vice president of Market Access in the US and in 2016 he was appointed Senior Vice President of Market Access in the US. In this role he was responsible for securing formulary access with key payer customers for Novo Nordisk brands. In March 2017 Mr Langa was appointed senior vice president, head of North America Operations and president of Novo Nordisk Inc., and in August 2017 Mr Langa was promoted to executive vice president, continuing his responsibilities as head of North America Operations and president of Novo Nordisk Inc. Mr. Langa represents Novo Nordisk Inc. on the Board of Directors of the trade association PhRMA.
 

Former positions

Mr Langa joined Novo Nordisk from GlaxoSmithKline, where he was the Senior Director of Payer Marketing. Prior to GlaxoSmithKline Mr Langa spent the majority of his career at Johnson and Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing.
 

Education

Mr Langa graduated from Widener University, US, in 1989 and earned an MBA from Fordham University, US, in 1997. Mr Langa also holds professional certificates from The Wharton School, 2012, and Harvard Business School, 2015.
 

Nationality and age

Mr Langa is a US national, born October 1966.